Multiplexed high content assay to measure endoplasmic reticulum stress for predictive toxicology

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201500028C
Awardee
Awarding agency
Obligated
$225,000

Award facts

Contract value 100% obligated
$225,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
San Francisco, CA 94158, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 1 $0
Original award $225,000

About this award

The National Center for Advancing Translational Sciences, a civilian agency, awarded a Firm Fixed Price definitive contract worth $225,000.00 to Cairn Biosciences Inc., a Woman Owned Small Business, for the development of a "MULTIPLEXED HIGH CONTENT ASSAY TO MEASURE ENDOPLASMIC RETICULUM STRESS FOR PREDICTIVE TOXICOLOGY". The contract has a total small business set-aside and is scheduled for completion by March 14, 2016.

Quick answers

Who was awarded contract HHSN271201500028C?

HHSN271201500028C was awarded to Cairn Biosciences Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on June 11, 2015.

How much is contract HHSN271201500028C worth?

The government has obligated $225,000 on HHSN271201500028C.

Was contract HHSN271201500028C competed?

The extent of competition for HHSN271201500028C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award